EUVIMEDEUVIMED entdecken
Crossref

Anti-TNF-α Treatment Improves the Live Birth Rate and Reduces the Risk of Premature Delivery in Patients with Recurrent Spontaneous Abortion

Shuxia Chen, Yuan Li, Chao Sun, Jiecheng Yang, Shaoying Li, Qiang Feng, Xin Feng, Zhe Li, Kejuan Zhang, Yuejun Liu

The Tohoku Journal of Experimental Medicine · 2025

DOI: 10.1620/tjem.2025.j103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2025. Verfasst von Shuxia Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Affiliated Hospital of Hebei Engineering University. Hauptthemen laut MEDLINE: Premature Birth, Live Birth, Abortion, Habitual, Tumor Necrosis Factor-alpha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunity and inflammation contribute to the development of recurrent spontaneous abortion (RSA); tumor necrosis factor inhibitor (TNFi) is a well-known anti-inflammation treatment for immune diseases. This study aimed to investigate the effect of TNFi on pregnancy outcomes and tolerance in RSA patients. This retrospective, observational study analyzed 115 RSA patients. Forty-three patients received TNFi plus intravenous immunoglobin (IVIG) and low molecular weight heparin (LMWH) treatment (the TNFi group), whereas another 72 patients received IVIG plus LMWH or LMWH alone treatment (the Control group). TNFi agents included certolizumab, etanercept, and adalimumab. The live birth rate was greater in the TNFi group than in the Control group (72.1% vs. 45.8%, P = 0.006), whereas the premature delivery rate tended to be lower in the TNFi group vs. the Control group but did not reach statistical significance (9.7% vs. 24.2%, P = 0.123). Multivariable logistic regression revealed that treatment (TNFi vs. Control) was independently correlated with greater live birth achievement (P = 0.001, odds ratio = 5.470); furthermore, treatment (TNFi vs. Control) tended to be independently associated with a reduced premature delivery risk (P = 0.055, odds ratio = 0.178). The type of labor (P = 0.321), neonatal birth weight (P = 0.159), and newborn Apgar score (P = 0.233) did not differ between the TNFi group and the Control group. Furthermore, adverse events, including rash, gestational hypertension, abnormal liver function index, ecchymosis, fever, and abnormal renal function index were not different between the TNFi and Control groups (all P > 0.05). TNFi improves live birth rate and tends to reduce premature delivery risk in RSA patients, providing a potential treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthLive BirthAbortion, HabitualTumor Necrosis Factor-alphaHumansFemalePregnancyAdultRisk FactorsPregnancy OutcomeRetrospective Studies

Stichwörter der Autor:innen

live birth ratepremature delivery raterecurrent spontaneous abortionsafety profiletumor necrosis factor inhibitor

Substanzen

Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Obstetrics, Affiliated Hospital of Hebei Engineering University.
  • Department of Obstetrics, HanDan Central Hospital.
  • Department of General Surgery, The Third Hospital of Han Dan.
  • Child Care, Merice Cody Public School.
  • Department of Cardiology, HanDan Central Hospital.
  • Department of Neurology, HanDan Central Hospital.

Zitieren

APA

Chen, S., Li, Y., Sun, C., Yang, J., Li, S., Feng, Q., Feng, X., Li, Z., Zhang, K., & Liu, Y. (2025). Anti-TNF-α Treatment Improves the Live Birth Rate and Reduces the Risk of Premature Delivery in Patients with Recurrent Spontaneous Abortion. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2025.j103

Vancouver

Chen S, Li Y, Sun C, Yang J, Li S, Feng Q, et al. Anti-TNF-α Treatment Improves the Live Birth Rate and Reduces the Risk of Premature Delivery in Patients with Recurrent Spontaneous Abortion. The Tohoku Journal of Experimental Medicine. 2025. doi:10.1620/tjem.2025.j103

BibTeX
@article{Chen2025,
  author = {Chen, Shuxia and Li, Yuan and Sun, Chao and Yang, Jiecheng and Li, Shaoying and Feng, Qiang and Feng, Xin and Li, Zhe and Zhang, Kejuan and Liu, Yuejun},
  title = {Anti-TNF-α Treatment Improves the Live Birth Rate and Reduces the Risk of Premature Delivery in Patients with Recurrent Spontaneous Abortion},
  journal = {The Tohoku Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1620/tjem.2025.j103}
}
Kostenlos starten →